Jim Simons 9 Meters Biopharma, Inc. Transaction History

Renaissance Technologies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.21 - $0.32 $250,509 - $381,728	1,192,900 Added 254.19%	1,662,200 $357,000
Q2 2022 Aug 12, 2022	SELL	$0.26 - $0.64 $462,228 - $1.14 Million	-1,777,800 Reduced 79.12%	469,300 $122,000
Q1 2022 May 13, 2022	BUY	$0.52 - $1.0 $1.17 Million - $2.25 Million	2,247,100 New	2,247,100 $1.35 Million
Q3 2021 Nov 12, 2021	SELL	$1.03 - $1.41 $1.34 Million - $1.84 Million	-1,305,027 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$1.04 - $1.5 $1.36 Million - $1.96 Million	1,305,027 New	1,305,027 $1.44 Million
Q1 2021 May 13, 2021	SELL	$0.84 - $2.16 $529,185 - $1.36 Million	-629,983 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$0.65 - $1.11 $189,959 - $324,393	292,246 Added 86.53%	629,983 $541,000
Q3 2020 Nov 13, 2020	BUY	$0.48 - $0.84 $100,289 - $175,507	208,937 Added 162.22%	337,737 $275,000
Q2 2020 Aug 13, 2020	BUY	$0.43 - $0.74 $55,384 - $95,312	128,800 New	128,800 $74,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.